Global Acute Bacterial Skin And Skin Structure Infections Market Size study, by Type of Infection, Route of Administration, Distribution Channel, and Regional Forecasts 2022-2032

Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market is valued approximately at USD 1.28 billion in 2023 and is anticipated to grow with a steady CAGR of more than 4.84% over the forecast period 2024-2032. ABSSSI includes a broad category of skin infections caused predominantly by gram-positive pathogens such as Staphylococcus aureus (including MRSA) and Streptococcus species. These infections, often resulting from trauma, post-surgical complications, or chronic wounds, demand swift intervention due to their rapid progression and high risk of systemic complications. The growing resistance to first-line antibiotics and an increasing aging population with comorbidities have significantly heightened the need for effective ABSSSI-targeted therapeutics with improved safety profiles and faster treatment timelines.

This clinical urgency has driven pharmaceutical companies to accelerate research on novel agents, combination therapies, and new-generation antibiotics that offer both bactericidal efficacy and low toxicity. The adoption of long-acting injectables and once-daily IV/oral options are gaining traction due to their compatibility with outpatient care models and reduced hospitalization burdens. Moreover, regulatory incentives for antimicrobial development, such as the GAIN (Generating Antibiotic Incentives Now) Act in the U.S., are encouraging market participants to bring innovative ABSSSI drugs to market swiftly. Nonetheless, despite robust clinical development, issues around pricing, limited patent windows, and the threat of antimicrobial resistance still challenge market scalability.

Technological progress in pathogen-specific diagnostics is catalyzing precision-based treatment approaches, enabling faster identification of causative organisms and their resistance profiles. This not only shortens the diagnostic-to-treatment window but also aids in antibiotic stewardship by reducing empirical prescribing. Distribution models are also evolving, with hospital pharmacies dominating due to intravenous administration needs, while the emergence of oral formulations and telehealth-assisted prescriptions is opening pathways for retail and online pharmacies to expand their share.

Regionally, North America leads the ABSSSI market, fueled by strong hospital infrastructure, higher disease awareness, and favorable reimbursement frameworks. The U.S. remains the focal point, thanks to early access to breakthrough therapies and the presence of major industry players. Europe follows closely, driven by rising hospitalization rates and coordinated efforts to manage antibiotic resistance. The Asia Pacific region, meanwhile, is expected to witness the fastest growth, propelled by increasing healthcare spending, rising infection rates, and broader access to branded and generic antibiotics. In nations such as China and India, the push for healthcare infrastructure reform and national antibiotic policy frameworks are expected to further bolster market growth.

Major market player included in this report are:
• Melinta Therapeutics Inc.
• Pfizer Inc.
• Merck & Co., Inc.
• Paratek Pharmaceuticals, Inc.
• Aurobindo Pharma Ltd.
• GlaxoSmithKline plc
• Wockhardt Ltd.
• Dr. Reddy’s Laboratories Ltd.
• Shionogi & Co., Ltd.
• Basilea Pharmaceutica Ltd.
• Tetraphase Pharmaceuticals, Inc.
• Venatorx Pharmaceuticals, Inc.
• Entasis Therapeutics Inc.
• Cipla Ltd.
• Sandoz International GmbH

The detailed segments and sub-segment of the market are explained below:

By Type of Infection
• Cellulitis
• Wound Infection
• Post-surgical Infection
• Others

By Route of Administration
• Oral
• Injectable

By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.